A novel orally active HDAC6 inhibitor T‑518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice. Scientific Reports, 2021 by Reaction Biology | Jul 6, 2023
Challenges in profiling and lead optimization of drug discovery for methyltransferases. Drug Discovery Today Technologies, 2015 by Reaction Biology | Jul 6, 2023
Probing PRMT5 inhibitors with distinct binding modes using surface plasmon resonance by Reaction Biology | Jul 6, 2023